Quotient Sciences Quotient Sciences

X

Digital content for Apotex Inc

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Apotex Inc
Canada Flag
Country
Country
Canada
Address
Address
150 Signet Drive, Toronto, Ontario, M9L 1T9
Telephone
Telephone
+1-800-268-4623
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/apotex-to-acquire-searchlight-pharma-a-canadian-specialty-branded-pharmaceutical-leader-302104981.html

PR NEWSWIRE
02 Apr 2024

https://www.indianpharmapost.com/news/apotex-to-acquire-canadian-searchlight-pharma-15470

INDIANPHARMAPOST
02 Apr 2024

https://www.businesswire.com/news/home/20240215859659/en

BUSINESSWIRE
15 Feb 2024

https://www.fiercepharma.com/pharma/apotex-heritage-and-breckenridge-settle-total-45m-yearslong-generics-price-fixing-case

FIERCE PHARMA
24 Jan 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213731

FDA
13 Dec 2023

https://www.businesswire.com/news/home/20231201964173/en

BUSINESSWIRE
01 Dec 2023

https://www.prnewswire.com/news-releases/apotex-corp-launches-teriparatide-injectable-for-osteoporosis-treatment-in-the-united-states-301995274.html

PR NEWSWIRE
21 Nov 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214875

FDA
06 Nov 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217695

FDA
23 Aug 2023

https://endpts.com/fda-to-import-more-of-cancer-drug-from-china/

Tyler Patchen ENDPTS
12 Jul 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY